A phase II trial of a chemotherapy combination in elderly patients with aggressive lymphoma.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/3AF97D73.svg?ark=w1%2F20260515%2F3AF97D73)](https://nobleid.org/work/w1/20260515/3AF97D73)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors